Tiziana Life Sciences (TLSA) Cash & Equivalents (2017 - 2026)
Tiziana Life Sciences (TLSA) posted Cash & Equivalents of $3.18 million for Q2 2026, down 56.2% from $7.25 million a year earlier.
Powered by 
Analysis
Tiziana Life Sciences (TLSA) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Tiziana Life Sciences' Cash & Equivalents came in at $4.01 million, up 7.7% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -42.9% (FY2020 to FY2025).
- In prior years, Tiziana Life Sciences' Cash & Equivalents was $3.72 million in FY2024 (+214.8%), $1.18 million in FY2023 (-93.5%), $18.12 million in FY2022 (-57.0%) and $42.19 million in FY2021 (-35.9%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q2 2024.
- On a year-over-year basis, Cash & Equivalents increased in three of the last four quarters, with growth averaging 177.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2025, with growth of 541.7%; the weakest was Q4 2023, with a decline of 93.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tiziana Life Sciences | 114.48 Mn | 96.32 Mn | - | 3.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Dec 31, 2022 | 18.12 Mn |
| Jun 30, 2022 | 26.54 Mn |
| Dec 31, 2021 | 42.19 Mn |
| Jun 30, 2021 | 53.28 Mn |
| Dec 31, 2020 | 65.82 Mn |
| Dec 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 5.30 Mn |
| Dec 31, 2017 | 64,000.00 |
API Access
Tiziana Life Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TLSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TLSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TLSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();